Cytokine Levels in Conversion Disorder

Conversion Disorder Clinical Trial

Official title:

Proinflammatory Cytokine Levels in Patients With Conversion Disorder

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00971360
• Other study ID #: TUTFEK 2009/173
• Status: Completed
• Phase: N/A
• First received: September 2, 2009
• Last updated: October 19, 2010
• Start date: September 2009
• Est. completion date: September 2010

Study information

• Verified date: September 2009
• Source: Trakya University
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review BoardTurkey: Ethics Committee
• Study type: Observational

Clinical Trial Summary

The aim of this study is whether the proinflammatory cytokine levels in patients with conversion disorder is increased or not changed in the acute phase and subacute - chronic periode, compared with controls.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 30
• Est. completion date: September 2010
• Est. primary completion date: September 2010
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• Clinical diagnosis of Alzheimer's Disease

Exclusion Criteria:

• Autoimmune disease

• Neurological disease

• Any organic disorder that could possibly affect proinflammatory cytokines

• Pregnancy

• Any drug usage within 2 weeks

• Any active or passive immunization within 6 months

• Any other DSM-IV axis I psychiatric disorder

• Mental retardation

• Developmental disorder of childhood

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Conversion Disorder
• Dissociative Disorders

Intervention

Other:
• conversion disorder
Proinflammatory cytokine levels in conversion disorder

Locations

Country	Name	City	State
Turkey	Trakya University Faculty of Medicine; Department of Psychiatry	Edirne

Sponsors (1)

Lead Sponsor	Collaborator
Trakya University

Country where clinical trial is conducted

Turkey, 

References & Publications (3)

Dantzer R. Somatization: a psychoneuroimmune perspective. Psychoneuroendocrinology. 2005 Nov;30(10):947-52. Review. — View Citation

Rief W, Pilger F, Ihle D, Bosmans E, Egyed B, Maes M. Immunological differences between patients with major depression and somatization syndrome. Psychiatry Res. 2001 Dec 31;105(3):165-74. — View Citation

Ziemssen T, Kern S. Psychoneuroimmunology--cross-talk between the immune and nervous systems. J Neurol. 2007 May;254 Suppl 2:II8-11. Review. Erratum in: J Neurol. 2008 Feb;255(2):309-10. — View Citation